Rational combination treatment with histone deacetylase inhibitors and immunomodulatory drugs in multiple myeloma
Teru Hideshima(Harvard University), K C Anderson(Harvard University)
Cited by 64
Related Papers
Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma
|Blood|2001|905
Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myeloma
|Proceedings of the National Academy of Sciences|2005|596